CFT7455 | m-entrepreneurship.com

Product Name :
CFT7455

Search keywords :
Ikaros

drugId :
null

Target Vo:
Zinc finger protein Aiolos

Target Vo Short Name :
IKZF3

Moa_Name:
Proteolysis

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
C4 Therapeutics Inc

Active Company_Name :
C4 Therapeutics Inc

Active Indication_Name:
Multiple Myeloma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
TCF7L2/TCF4 Antibody
SQSTM1/p62 Antibody (YA062)
beta Arrestin 1 Antibody (YA822): beta Arrestin 1 Antibody (YA822) is a non-conjugated and Mouse origined monoclonal antibody about 47 kDa, targeting to beta Arrestin 1 (6A1). It can be used for WB assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts